Quarterly ResultApr 30, 2026, 04:36 PM
EMN Q1 Adj EPS $1.09, Revenue $2.18B; Q2 Adj EPS Outlook $1.70-$1.90
AI Summary
Eastman Chemical Company reported Q1 2026 adjusted EPS of $1.09 and sales revenue of $2.177 billion, representing significant year-over-year declines. Despite the decrease, the company achieved strong sequential sales volume/mix improvement in specialty businesses and is implementing substantial price increases to offset inflation. Management anticipates the Middle East conflict to create net upside to earnings, particularly in Chemical Intermediates, and projects Q2 2026 adjusted EPS between $1.70 and $1.90, signaling a more positive outlook for the upcoming quarter.
Key Highlights
- EMN Q1 2026 Adjusted EPS was $1.09, down 42.9% from $1.91 in Q1 2025.
- Q1 2026 Sales Revenue was $2.177 billion, a 5% decrease from $2.290 billion in Q1 2025.
- Q1 2026 Adjusted EBIT was $200 million, down 35.7% from $311 million in Q1 2025.
- Specialty businesses delivered strong sequential sales volume/mix improvement of over 10%.
- Company is implementing approximately $500 million of price increases across its portfolio.
- Q2 2026 adjusted EPS is projected to be in the range of $1.70 to $1.90.
- Net cash used in operating activities improved to $(137) million from $(167) million year-over-year.
- Advanced Materials sales revenue decreased 1% to $715 million.
- Fibers sales revenue decreased 22% to $225 million.